⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4554902 | 0.93 | — | — | |
| SCHEMBL9614870 | 0.62 | — | — | |
| SCHEMBL5983448 | 0.58 | — | — | |
| SCHEMBL8719021 | 0.57 | — | — | |
| SCHEMBL11228217 | 0.57 | — | — | |
| SCHEMBL30323640 | 0.56 | — | — | |
| SCHEMBL10960595 | 0.55 | GSK3A (0.32) | — | |
| SCHEMBL10842659 | 0.55 | — | — | |
| SCHEMBL8709772 | 0.53 | — | — | |
| SCHEMBL168677 | 0.52 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0329904-A1 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329932-A2 | Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments | MERRELL PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | disclosed |